Institutional Review Boards (IRBs) are mandated by the Food and Drug Administration to oversee all clinical trials in humans. They review and approve all trial plans (called protocols), ensure that the patient is informed about risks, and enforce ethical conduct of the healthcare professionals during the research study. CNS Healthcare works closely with IRB's to adhere to patient safety and the highest ethics standards.